Dr. Ricardo Carter, MD

Media Releases

Get to know Hematologist-Oncologist Dr. Ricardo Carter, who serves patients in Lewistown, Pennsylvania.

An established hematologist-oncologist, Dr. Carter has been in private practice in Lewistown, Pennsylvania since 1991. He offers oncology and hematology evaluation and diagnosis, as well as clinical trials through Eastern Cooperative Oncology Group.

Some of the services that he provides at his practice include 24-Hour chemotherapy on ambulatory pumps for home chemotherapy, biotherapy, cancer clinical trials, chemotherapy, hormonal therapy, immunotherapy, and iron therapy. 

“Our mission is to provide state-of-the-art treatments in a community setting for patients with cancer and blood disorders. This practice works with other major medical centers to provide a coordinated team approach to your treatment. We believe in the importance of continuity of care for our patients so we provide twenty-four hour inpatient and outpatient care provided by a physician” as stated on his website. 

Back in 1981, Dr. Carter graduated from the University of Xochicalco School of Medicine in Mexico. He then relocated to the United States, performing his residency in internal medicine at Lutheran Medical Center in 1985, and his fellowship in hematology and oncology at Jamaica Plain VA Medical Center in 1988.

On a professional level, he is an active member of the American College of Physicians, and is affiliated with Geisinger Medical Center.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, sickle-cell disease, and a rare hematologic related syndromes, and diseases.

Recommended Articles

• Can Multiple Myeloma be Asymptomatic?

  Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...

• 'Robocop' Stem Cells Developed to Fight Cancer

  Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...

• Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients

  Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...

• Dance Mom Abby Lee Miller Diagnosed with Non-Hodgkin Lymphoma

  Abby Lee Miller, known for her brutal dance instruction and demanding style of training, is as recognized for her tirades as she is for her long-running hit reality show Dance Moms.Abby inherited the love of dance from her late mother and started her own dance company at just 14 years old. She...

• Treatment Options of Multiple Myeloma

  A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...